Title : Trabectedin efficacy in Ewing sarcoma is greatly increased by combination with anti-IGF signaling agents.

Pub. Date : 2015 Mar 15

PMID : 25609059






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: We confirm that both trabectedin and doxorubicin were able to strongly reduce EWS-FLI1 (both type I and type II) binding to two representative target genes (TGFbetaR2 and CD99), both in vitro and in xenografts. Trabectedin Fli-1 proto-oncogene, ETS transcription factor Homo sapiens
2 However, trabectedin, but not doxorubicin, was also able to increase the occupancy of EWS-FLI1 to IGF1R promoters, leading to IGF1R upregulation. Trabectedin Fli-1 proto-oncogene, ETS transcription factor Homo sapiens